• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes.人外周血单核细胞对补体成分及替代补体途径调节蛋白的生物合成
J Exp Med. 1980 Mar 1;151(3):501-16. doi: 10.1084/jem.151.3.501.
2
Increased biosynthesis of complement components by cultured monocytes, synovial fluid macrophages and skynovial membrane cells from patients with rheumatoid arthritis.类风湿关节炎患者的培养单核细胞、滑液巨噬细胞和滑膜细胞中补体成分的生物合成增加。
Immunology. 1980 Sep;41(1):37-43.
3
[Alternative complement pathway (author's transl)].替代补体途径(作者译)
Nouv Presse Med. 1979 Jun 9;8(26):2187-94.
4
Alternative pathway of complement.补体替代途径
Methods Enzymol. 1988;162:639-53. doi: 10.1016/0076-6879(88)62106-9.
5
Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.C3b灭活因子和β1H球蛋白在系统性红斑狼疮中对备解素放大环调节作用的相对重要性
Clin Exp Immunol. 1979 Jun;36(3):408-14.
6
Complement C3 convertase: cell surface restriction of beta1H control and generation of restriction on neuraminidase-treated cells.补体C3转化酶:β1H调控的细胞表面限制及神经氨酸酶处理细胞上限制的产生
Proc Natl Acad Sci U S A. 1978 May;75(5):2416-20. doi: 10.1073/pnas.75.5.2416.
7
Synthesis of factors D, B and P of the alternative pathway of complement activation, as well as of C3, by guinea-pig peritoneal macrophages in vitro.豚鼠腹腔巨噬细胞体外合成补体激活替代途径的D因子、B因子和P因子以及C3。
Immunology. 1978 Dec;35(6):971-80.
8
Activation of the alternative complement pathway.替代补体途径的激活。
CRC Crit Rev Immunol. 1979 Nov;1(1):1-32.
9
Synthesis of complement components (C3, C2, B and C1-inhibitor) and lysozyme by human monocytes and macrophages.人单核细胞和巨噬细胞对补体成分(C3、C2、B和C1抑制剂)及溶菌酶的合成。
J Clin Lab Immunol. 1986 Jul;20(3):101-5.
10
The binding of human complement proteins C5, factor B, beta 1H and properdin to complement fragment C3b on zymosan.人补体蛋白C5、B因子、β1H和备解素与酵母聚糖上的补体片段C3b的结合。
Biochem J. 1981 Dec 1;199(3):485-96. doi: 10.1042/bj1990485.

引用本文的文献

1
The secret life of complement: challenges and opportunities in exploring functions of the complosome in disease.补体的隐秘生活:探索补体小体在疾病中的功能所面临的挑战与机遇
J Clin Invest. 2025 Jun 16;135(12). doi: 10.1172/JCI188350.
2
Common Haplotypes within the Chromosome 1q31.3 Region Determine Systemic Concentrations of the Entire Complement Factor H Protein Family.1号染色体1q31.3区域内的常见单倍型决定整个补体因子H蛋白家族的系统浓度。
J Innate Immun. 2025;17(1):244-261. doi: 10.1159/000545342. Epub 2025 Mar 26.
3
The human factor H protein family - an update.人因子 H 蛋白家族——更新。
Front Immunol. 2024 Feb 12;15:1135490. doi: 10.3389/fimmu.2024.1135490. eCollection 2024.
4
Single-cell RNA-seq reveals alterations in peripheral CX3CR1 and nonclassical monocytes in familial tauopathy.单细胞 RNA 测序揭示家族性 tau 病外周 CX3CR1 和非经典单核细胞的改变。
Genome Med. 2023 Jul 18;15(1):53. doi: 10.1186/s13073-023-01205-3.
5
Cervicovaginal Complement Activation and Microbiota During Pregnancy and in Parturition.妊娠期和分娩期宫颈阴道补体激活与微生物群。
Front Immunol. 2022 Jul 25;13:925630. doi: 10.3389/fimmu.2022.925630. eCollection 2022.
6
Novel interaction of properdin and coagulation factor XI: Crosstalk between complement and coagulation.备解素与凝血因子XI的新型相互作用:补体与凝血之间的串扰
Res Pract Thromb Haemost. 2022 May 24;6(4):e12715. doi: 10.1002/rth2.12715. eCollection 2022 May.
7
Complement Factor D (adipsin) Levels Are Elevated in Acquired Partial Lipodystrophy (Barraquer-Simons syndrome).补体因子 D(脂联素)水平在获得性部分脂肪营养不良(Barraquer-Simons 综合征)中升高。
Int J Mol Sci. 2021 Jun 21;22(12):6608. doi: 10.3390/ijms22126608.
8
Aberrant activation of the complement system in renal grafts is mediated by cold storage.在肾脏移植物中,补体系统的异常激活是由冷储存介导的。
Am J Physiol Renal Physiol. 2021 Jun 1;320(6):F1174-F1190. doi: 10.1152/ajprenal.00670.2020. Epub 2021 May 17.
9
Cross-Talk between the Complement Pathway and the Contact Activation System of Coagulation: Activated Factor XI Neutralizes Complement Factor H.补体途径与凝血接触激活系统的串扰:激活的因子 XI 中和补体因子 H。
J Immunol. 2021 Apr 15;206(8):1784-1792. doi: 10.4049/jimmunol.2000398.
10
Predictors of HbA1c among Adipocytokine Biomarkers in African-American Men with Varied Glucose Tolerance.不同糖耐量的非裔美国男性中,脂肪细胞因子生物标志物里糖化血红蛋白(HbA1c)的预测指标
Biomedicines. 2020 Nov 20;8(11):520. doi: 10.3390/biomedicines8110520.

本文引用的文献

1
The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement.人血清中“胶固素激活因子”的证实及其对补体第三成分的作用。
J Immunol. 1968 Apr;100(4):691-8.
2
Immune hemolysis and the functional properties of the second (C2) and fourth (C4) components of complement. 3. The hemolytic efficiency of human and guinea pig C2 and C4.免疫溶血及补体第二成分(C2)和第四成分(C4)的功能特性。3. 人和豚鼠C2及C4的溶血效率。
J Immunol. 1971 Apr;106(4):927-31.
3
The stoichiometric measurement of the serum inhibition of the first component of complement by the inhibition of immune hemolysis.通过免疫溶血抑制来进行血清对补体第一成分抑制作用的化学计量测量。
J Immunol. 1968 Jun;100(6):1154-64.
4
Properdin factor D: characterization of its active site and isolation of the precursor form.备解素因子D:其活性位点的表征及前体形式的分离。
J Exp Med. 1974 Feb 1;139(2):355-66. doi: 10.1084/jem.139.2.355.
5
Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3).替代补体途径:参与眼镜蛇毒因子(CoVF)激活补体第三成分(C3)的相关因子。
J Immunol. 1973 Jan;110(1):128-38.
6
Formation of the C3-cleaving properdin enzyme on zymosan. Demonstration that factor D is replaceable by proteolytic enzymes.酵母聚糖上C3裂解备解素酶的形成。证明因子D可被蛋白水解酶替代。
J Immunol. 1974 Dec;113(6):1735-43.
7
Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis.关于人补体成分5的进一步研究:改进纯化方法的开发以及通过聚丙烯酰胺凝胶电泳对纯化产物进行表征
Immunochemistry. 1972 Jul;9(7):709-23. doi: 10.1016/0019-2791(72)90015-8.
8
Properdin factor D. II. Activation to D by properdin.备解素因子D。二、备解素将其激活为D。
J Exp Med. 1974 Aug 1;140(2):426-36. doi: 10.1084/jem.140.2.426.
9
Isolation and removal of lymphocytes from bone marrow of rats and guinea-pigs.从大鼠和豚鼠骨髓中分离并去除淋巴细胞。
Scand J Clin Lab Invest Suppl. 1968;97:91-106.
10
Chemistry and reaction mechanisms of complement.补体的化学性质及反应机制
Adv Immunol. 1968;8:1-80. doi: 10.1016/s0065-2776(08)60464-2.

人外周血单核细胞对补体成分及替代补体途径调节蛋白的生物合成

Biosynthesis of the complement components and the regulatory proteins of the alternative complement pathway by human peripheral blood monocytes.

作者信息

Whaley K

出版信息

J Exp Med. 1980 Mar 1;151(3):501-16. doi: 10.1084/jem.151.3.501.

DOI:10.1084/jem.151.3.501
PMID:6444659
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2185797/
Abstract

Short-term cultures of human peripheral blood monocytes were shown to synthesize the alternative pathway complement components C3, factors B (B) and D (D), and properdin, the regulatory proteins C3b inactivator (C3bINA) and beta 1H, in addition to C2, C4, and C5. B, D, properdin, C3bINA, and C2 were detected by functional assays, whereas beta 1H, C4, C3, and C5 could only be detected using immunochemical procedures. Immunoperoxidase localization studies showed that all the cells in each culture contained each component, so it is possible that all monocytes synthesize each component. It is concluded that cells of the monocyte-macrophage series form a mobile source of complement components and regulatory proteins which can be concentrated at sites of inflammation.

摘要

人外周血单核细胞的短期培养物已显示能合成替代途径补体成分C3、B因子(B)和D因子(D)以及备解素,调节蛋白C3b灭活剂(C3bINA)和β1H,此外还能合成C2、C4和C5。通过功能测定法检测到B、D、备解素、C3bINA和C2,而β1H、C4、C3和C5只能使用免疫化学方法检测。免疫过氧化物酶定位研究表明,每种培养物中的所有细胞都含有每种成分,因此所有单核细胞都有可能合成每种成分。得出的结论是,单核细胞-巨噬细胞系列的细胞形成了补体成分和调节蛋白的流动来源,这些成分和蛋白可集中在炎症部位。